Cite
MLA Citation
E. M. Ewara et al.. “SAT0209 A comparative real-world utilization patterns of innovator and biosimilar infliximab in a treatment naÏve and switch population from germany: a prescription claims analysis.” Annals of the rheumatic diseases, vol. 77, n.d., p. 965. http://access.bl.uk/ark:/81055/vdc_100144725655.0x000052